CRWV is down 17% over the past month and off nearly 12% on the week alone — a steep reversal that looks especially pointed given how aggressively insiders were reducing positions ahead of the June 8 print.
The ownership table tells the most interesting story this week. Four of the five largest individual holders — CEO Michael Intrator, co-founders Brian Venturo and Brannin McBee, and director Jack Cogen — all reported material reductions in their positions. Venturo trimmed by nearly 7 million shares. Intrator reduced by close to 3 million. Cogen shed 2 million shares as recently as May 29. The timing is notable: these disposals were filed while the stock still traded well above current levels, and the June 8 earnings call delivered a negative first-day move of around 1.9%. The stock has continued lower since. On the institutional side, Goldman Sachs and Vanguard entities both reported fresh positions at end of Q1, adding roughly 8.8 million and 25 million shares combined — a contrasting signal from longer-horizon money that was building while insiders trimmed.
The lending market offers no drama to match the ownership story. The snapshot data here is from the Canadian TSX listing, which carries only a nominal short position of 21,724 shares — a number that has been flat for days and is not comparable to the significant short interest documented in earlier notes on the primary US listing. Cost to borrow on this listing has crept higher, rising from 3.2% at the start of June to 4.3%, but that remains a modest rate in absolute terms and does not signal any borrow stress. The ORTEX short score has drifted slightly lower over the past week, from around 28.1 to 27.5 — a low reading that puts CRWV in the bottom fifth of names on short-score rank, meaning the overall positioning signal is not one of elevated short pressure.
What the factor scores do flag is a divergence in analyst sentiment versus fundamental momentum. CRWV ranks in the 95th percentile on analyst recommendation differential — meaning the Street is more unanimously bullish on this name relative to peers than almost any other stock in the universe. The 83rd-percentile EPS surprise rank reinforces that the company has been beating estimates. But the 30-day EPS momentum rank has pulled back to the 19th percentile, and the 12-month forward EPS growth rank sits at just 25 — indicating that while the company has beaten, forward estimates are not accelerating. The valuation data available is stale (as of December 2025 year-end), so no current multiples can be cited with confidence. What the recent notes have flagged — a $99.4 billion revenue backlog, $40 billion in new Q1 customer commitments, a price-to-book above 8x with negative free cash flow — frames a business spending aggressively to capture AI infrastructure demand, with execution risk still the central debate.
The next scheduled earnings event is August 6. Between now and then, the primary things to watch are whether the post-earnings price weakness stabilises and draws additional institutional accumulation, whether the insider selling cadence continues into the next reporting window, and whether the analyst consensus — currently the most bullish in the universe — begins to show any cracks in the form of target reductions or rating downgrades following the post-June 8 drawdown.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
